Essential storage keeps sign-in, your bag and requested features working. With your permission, optional analytics, sampled session replay, error reports and affiliate tools help us understand and improve the site.
You can use the site without optional tracking and change your choice from the footer. Read the cookie details.
Paste any product's ingredient list. We flag what dermatology guidance says to avoid or use with caution during pregnancy, what's generally considered fine — and we cite every call. This is an educational screen, not medical advice.
Strong dermatology consensus is to avoid topical retinoids in pregnancy. Oral retinoids are proven teratogens; topical absorption is low (~1–2% for tretinoin) and prospective human studies have not shown a clear rise in malformations, but because the same vitamin-A signalling pathway is involved, the risk-benefit ratio is judged unfavourable and guidelines contraindicate them. This is precaution, not evidence of harm from creams.
Best avoided in pregnancy — not because harm is proven (a small human series showed no increase in adverse events) but because systemic absorption is unusually high for a topical: roughly 35–45% of an applied dose is absorbed, far more than most actives. With well-tolerated brightening alternatives available (azelaic acid, vitamin C, niacinamide + sunscreen), the cautious course is to skip it.
No skincare product should contain mercury — and it matters doubly in pregnancy. It's an illegal-but-still-circulating skin-lightening/preservative ingredient, readily absorbed through the skin, and it can damage the kidneys and nervous system. Pregnant women, nursing infants and young children are especially vulnerable, and mercury passes into breast milk. The FDA says stop using any product listing 'mercury', 'mercurous chloride', 'calomel', 'mercuric', or 'mercurio' on the label.
Depends on dose and area. Low-concentration, rinse-off or leave-on OTC salicylic acid (the ~0.5–2% in most cleansers/toners) is endorsed by ACOG for use in pregnancy — absorption is minimal over small areas. The caution is for HIGH-strength salicylic peels and whole-body or occluded use, where salicylate exposure is higher; those are best deferred. Evidence for real-world topical risk is limited, so this is a concentration nuance, not a blanket ban.
A glycosylated form of hydroquinone that slowly releases a small amount of hydroquinone on skin — one review found topical 2% arbutin gives only about 0.27±0.13% dermal absorption, with α-arbutin partially hydrolysing to hydroquinone in the skin. Systemic exposure is far lower than hydroquinone itself, but pregnancy-specific outcome data are essentially absent, so it sits in 'probably low risk — use only if your clinician is comfortable', with azelaic acid or vitamin C as better-characterised swaps.
A brightening agent with very low systemic absorption. There's no human reproductive-safety data — a mouse study found no maternal or fetal damage, which is reassuring but doesn't establish safety in pregnant humans — and reviews still say it's 'not recommended, and further studies are required.' It's flagged as unstudied in humans, not as harmful; prefer better-characterised options during pregnancy.
The concern is theoretical and the evidence limited. Oxybenzone (benzophenone-3) is absorbed (~1–2%, detectable in urine) and has endocrine-disrupting activity in lab and animal studies; a direct effect on human pregnancy is NOT established. Reviews advise using chemical filters with caution and prefer mineral sunscreen (zinc oxide / titanium dioxide) as a simple, well-tolerated swap; guidance is firmest for oxybenzone and octinoxate specifically (some reviews advise avoiding those two outright) and lighter for octocrylene / octisalate. Do not stop using sunscreen — just consider a mineral one.
Essential oils are highly concentrated, and a specific subset has documented reproductive-toxicity signals: pennyroyal (its pulegone is hepatotoxic and a historical cause of poisoning-induced miscarriage), wintergreen (essentially pure methyl salicylate — the same class of concern as oral aspirin), the thujone-rich oils sage, wormwood, mugwort, thuja and tansy (thujone is a convulsant and reproductive toxin), camphor (crosses the placenta to fetal organs), and hyssop/basil (neurotoxic / estragole carcinogenic-potential concerns). Most of this evidence is from animal studies or high-dose or ingested exposure, not low-concentration cosmetic use, so treat it as a reason for caution, not alarm. Rosemary and clary sage are sometimes cautioned against too, but the leading essential-oil-safety literature considers that unsupported at cosmetic-use levels — a lower priority within this caution than the oils above.
Topical minoxidil (the hair-regrowth active, and a popular postpartum-shedding fix) has no controlled human pregnancy-safety data. A published case report links maternal use to significant fetal brain, heart and vascular malformations, and the OTC drug label itself warns it 'may be harmful if used when pregnant or breast-feeding.' Better to pause it until after pregnancy/breastfeeding, on a clinician's advice.
Generally considered fine in pregnancy and a first-line acne option per ACOG. About 5% is absorbed through skin and is then fully metabolised to benzoic acid and excreted, so systemic exposure is very low; no signal for congenital malformation. Start low (2.5%).
One of the preferred actives in pregnancy — it tackles acne, redness and pigment. It occurs naturally in grains, absorption is low (~3–8%), and animal studies showed no harm at high doses. A practical, evidence-supported choice — the reviews just add the sensible caveat to keep it to smaller areas and, for maximum caution, to hold off in the first trimester.
Low-strength AHAs are considered well-tolerated topically — reviews put the reassuring range at up to ~10% with pH above 3.5, where systemic absorption is minimal. As with salicylic acid, the only real caution is high-percentage in-office peels. Keep daily SPF, since AHAs raise UV sensitivity.
Widely regarded as one of the safest pregnancy actives — a form of vitamin B3 that supports the barrier, calms redness and helps pigment. There's no dedicated niacinamide pregnancy study; the closest real evidence is the Cosmetic Ingredient Review Expert Panel's cosmetic-safety assessment — some in-vitro developmental-toxicity testing was mixed, but the Panel's overall conclusion was that niacinamide is well-tolerated as used at cosmetic concentrations, with decades of real-world use and no reported pregnancy-harm signal. That's reassurance from a general ingredient-safety review, not a pregnancy trial.
Considered well-tolerated in pregnancy — it is an antioxidant the body already makes and uses, with no contraindication reported for topical use. A good brightening alternative to the ingredients you're skipping. Evidence is reassurance-by-absence rather than a trial.
Considered well-tolerated and can be used freely — it is a large humectant molecule native to skin that mainly holds water at the surface, posing minimal systemic risk.
The preferred sunscreen filters in pregnancy — these inorganic minerals sit on the skin surface and reflect UV with negligible absorption, and are FDA GRASE. Sun protection matters more than ever because pregnancy raises melasma risk.
We match each ingredient on your label against a small, hand-curated rule set drawn from peer-reviewed reviews and dermatology-authority guidance (ACOG-aligned MotherToBaby fact sheets, Canadian Family Physician, and journal reviews — every flag links its source). Matching is literal substring matching on ingredient names, so a rule fires only when a known token is present. We grade each flag's evidence honestly: 'strong' means human/regulatory consensus, 'limited' means the basis is mechanistic or simply an absence of a safety signal.
This tool is conservative but imperfect. It can miss ingredients we don't have a rule for (an unflagged ingredient is NOT a guarantee of safety — it may just be unstudied), and it cannot see concentration, which changes the answer for dose-dependent ingredients like salicylic acid and AHAs. Much of the 'safe' evidence is reassurance-by-absence, not a dedicated pregnancy trial. It does not account for your medical history, trimester, or a product's full formulation.
Last verified July 2026. Citations and regulatory status (FDA rulings, EU bans, retracted studies) can change over time — every source link on this page is checked weekly for dead or moved URLs, and this lens is re-audited on its underlying evidence at least once a year. See our full bibliography →